ArticleFrontiers in immunology2020

C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice.

Nirmal K Banda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.